Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data von Klein, T E, Altman, R B, Eriksson, N, Gage, B F, Kimmel, S E, Lee, M-T M, Limdi, N A, Page, D, Roden, D M, Wagner, M J, Caldwell, M D, Johnson, J A

Volltext

Demonstration and Assessment of a Simple Viscosity Experiment for High School Science Classes von Floyd­-Smith, T. M, Kwon, K. C, Burmester, J. A, Dale, F. F, Vahdat, N, Jones, P

Volltext

Monumenta diluvii universalis ex historia naturali von Stobaeus, Kilian

Volltext bestellen

HOUR-GLASS CONTRACTION OF THE UTERUS, AND RETAINED PLACENTA von Burmester, A.J.

Volltext

EXTRACTION OF CALCULI FROM THE URETHRA von Burmester, A.J.

Volltext

2016 update of the EULAR recommendations for the management of early arthritis von Combe, B, Landewe, R, Daien, CI, Hua, C, Aletaha, D, Alvaro-Gracia, JM, Bakkers, M, Brodin, N, Burmester, GR, Codreanu, C, Conway, R, Dougados, M, Emery, P, Ferraccioli, G, Fonseca, J, Raza, K, Silva-Fernandez, L, Smolen, JS, Skingle, D, Szekanecz, Z, Kvien, TK, van der Helm-van Mil, A, van Vollenhoven, R

Volltext

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial von Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M

Volltext

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, pso... von Burmester, Gerd R, Panaccione, Remo, Gordon, Kenneth B, McIlraith, Melissa J, Lacerda, Ana P M

Volltext

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, doubl... von Nash, Peter, Prof, Kirkham, Bruce, Prof, Okada, Masato, MD, Rahman, Proton, Prof, Combe, Benard, Prof, Burmester, Gerd-Ruediger, Prof, Adams, David H, PhD, Kerr, Lisa, MSPH, Lee, Chin, MD, Shuler, Catherine L, MS, Genovese, Mark, Prof

Volltext

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative von Aletaha, Daniel, Neogi, Tuhina, Silman, Alan J, Funovits, Julia, Felson, David T, Bingham, Clifton O, Birnbaum, Neal S, Burmester, Gerd R, Bykerk, Vivian P, Cohen, Marc D, Combe, Bernard, Costenbader, Karen H, Dougados, Maxime, Emery, Paul, Ferraccioli, Gianfranco, Hazes, Johanna MW, Hobbs, Kathryn, Huizinga, Tom WJ, Kavanaugh, Arthur, Kay, Jonathan, Kvien, Tore K, Laing, Timothy, Mease, Philip, Ménard, Henri A, Moreland, Larry W, Naden, Raymond L, Pincus, Theodore, Smolen, Josef S, Stanislawska-Biernat, Ewa, Symmons, Deborah, Tak, Paul P, Upchurch, Katherine S, Vencovský, Jiří, Wolfe, Frederick, Hawker, Gillian

Volltext

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis von Ramiro, S, Sepriano, A, Chatzidionysiou, K, Nam, JL, Smolen, JS, van der Heijde, D, Dougados, M, van Vollenhoven, R, Bijlsma, JW, Burmester, GR, Scholte-Voshaar, M, Falzon, L, Landewe, RBM

Volltext

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update von Smolen, JS, Landewe, RBM, Bijlsma, JWJ, Burmester, GR, Dougados, M, Kerschbaumer, A, McInnes, IB, Sepriano, A, van Vollenhoven, RF, de Wit, M, Aletaha, D, Aringer, M, Askling, J, Balsa, A, Boers, M, den Broeder, AA, Buch, MH, Buttgereit, F, Caporali, R, Cardiel, MH, De Cock, D, Codreanu, C, Cutolo, M, Edwards, CJ, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gossec, L, Gottenberg, JE, Hetland, ML, Huizinga, TWJ, Koloumas, M, Li, ZG, Mariette, X, Muller-Ladner, U, Mysler, EF, da Silva, JAP, Poor, G, Pope, JE, Rubbert-Roth, A, Ruyssen-Witrand, A, Saag, KG, Strangfeld, A, Takeuchi, T, Voshaar, M, Westhovens, R, van der Heijde, D

Volltext

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid... von Nam, JL, Takase-Minegishi, K, Ramiro, S, Chatzidionysiou, K, Smolen, JS, van der Heijde, D, Bijlsma, JW, Burmester, GR, Dougados, M, Scholte-Voshaar, M, van Vollenhoven, R, Landewe, R

Volltext

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update von Smolen, JS, Landewe, RBM, Bergstra, SA, Kerschbaumer, A, Sepriano, A, Aletaha, D, Caporali, R, Edwards, CJ, Hyrich, KL, Pope, JE, de Souza, S, Stamm, TA, Takeuchi, T, Verschueren, P, Winthrop, KL, Balsa, A, Bathon, JM, Buch, MH, Burmester, GR, Buttgereit, F, Cardiel, MH, Chatzidionysiou, K, Codreanu, C, Cutolo, M, den Broeder, AA, El Aoufy, K, Finckh, A, Fonseca, JE, Gottenberg, JE, Haavardsholm, EA, Iagnocco, A, Lauper, K, Li, ZG, McInnes, IB, Mysler, EF, Nash, P, Poor, G, Ristic, GG, Rivellese, F, Rubbert-Roth, A, Schulze-Koops, H, Stoilov, N, Strangfeld, A, van der Helm-van Mil, A, van Duuren, E, Vlieland, TPMV, Westhovens, R, van der Heijde, D

Volltext

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists von Lee, H-H., Song, I-H., Friedrich, M., Gauliard, A., Detert, J., Röwert, J., Audring, H., Kary, S., Burmester, G.-R., Sterry, W., Worm, M.

Volltext

Treatment of relapsing polychondritis: a systematic review von Petitdemange, Arthur, Sztejkowski, Cédric, Damian, Laura, Martin, Thierry, Mouthon, Luc, Amoura, Zahir, Cutolo, Maurizio, Burmester, Gerd R, Fonseca, João E, Rednic, Simona, Arnaud, Laurent

Volltext

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial von Smolen, J, Landewé, R B, Mease, P, Brzezicki, J, Mason, D, Luijtens, K, van Vollenhoven, R F, Kavanaugh, A, Schiff, M, Burmester, G R, Strand, V, Vencovský, J, van der Heijde, D

Volltext

Identification of novel therapeutic targets for blocking acantholysis in pemphigus von Burmester, Imke A.K., Flaswinkel, Sarah, Thies, Clara‐Sophie, Kasprick, Anika, Kamaguchi, Mayumi, Bumiller‐Bini, Valéria, Emtenani, Shirin, Feldmann, Nick, Kridin, Khalaf, Schmidt, Enno, Beek, Nina, Zillikens, Detlef, Hammers, Christoph M., Hundt, Jennifer E., Ludwig, Ralf J.

Volltext

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised... von Schnitzer, Thomas J, Burmester, Gerd R, Mysler, Eduardo, Hochberg, Marc C, Doherty, Michael, Ehrsam, Elena, Gitton, Xavier, Krammer, Gerhard, Mellein, Bernhard, Matchaba, Patrice, Gimona, Alberto, Hawkey, Christopher J

Volltext

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force von Smolen, Josef S, Breedveld, Ferdinand C, Burmester, Gerd R, Bykerk, Vivian, Dougados, Maxime, Emery, Paul, Kvien, Tore K, Navarro-Compán, M Victoria, Oliver, Susan, Schoels, Monika, Scholte-Voshaar, Marieke, Stamm, Tanja, Stoffer, Michaela, Takeuchi, Tsutomu, Aletaha, Daniel, Andreu, Jose Louis, Aringer, Martin, Bergman, Martin, Betteridge, Neil, Bijlsma, Hans, Burkhardt, Harald, Cardiel, Mario, Combe, Bernard, Durez, Patrick, Fonseca, Joao Eurico, Gibofsky, Alan, Gomez-Reino, Juan J, Graninger, Winfried, Hannonen, Pekka, Haraoui, Boulos, Kouloumas, Marios, Landewe, Robert, Martin-Mola, Emilio, Nash, Peter, Ostergaard, Mikkel, Östör, Andrew, Richards, Pam, Sokka-Isler, Tuulikki, Thorne, Carter, Tzioufas, Athanasios G, van Vollenhoven, Ronald, de Wit, Martinus, van der Heijde, Desirée

Volltext